Skip to main content

Samlyn Capital, LLC

SEC CIK
0001421097
Latest filing
Aug 14, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Samlyn Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q3 2023
Holdings of SAGE by Samlyn Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−594,661−100.0%Sold outHolders
Q1 2024594,661$11.1M0.2%−174,241−22.7%ReducedHolders
Q4 2023768,902$16.7M0.4%+29,035+3.9%AddedHolders
Q3 2023739,867$15.2M0.3%+739,867NewHolders